Picture of Vivesto AB logo

VIVE Vivesto AB Cashflow Statement

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Annual cashflow statement for Vivesto AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

2020
April 30th
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-30.1-129-355-132-42
Depreciation
Non-Cash Items22.10
Other Non-Cash Items
Changes in Working Capital1.08-45.818.46.05-10.2
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-6.87-146-80.5-68.7-47.2
Capital Expenditures-12.9-34.3-0.277-0.6590
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-275153-4564.443.4
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities-288119-45.363.743.4
Financing Cash Flow Items-26.7-16.40
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities380-5.811290
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash84.7-32.21.55-5.18-3.51